tests in the broader context of patient health management, advising that results should be interpreted by qualified clinicians. The company operates on a fee-for-service basis and does not engage with insurance providers for billing, including Medicare. This approach ensures direct access to their specialized testing services for healthcare providers and patients seeking detailed insights into mycotoxin-related health issues.